[Alpha Biz= Reporter Kim Sangjin] Daol Investment & Securities issued a "Buy" rating and a target price of 80,000 KRW for APR on December 5, anticipating a strong Q4 performance driven by growth in North American sales.
The firm explained, "Based on Google Trends and Amazon bestseller rankings during Black Friday, we expect APR’s North American sales to perform well in Q4. The MediCube brand surpassed K-beauty indie brands COSRX and Chosun Beauty in Google Trends."
Additionally, Daol noted that APR’s main product, BoosterPro, maintains its position as the top product in the anti-aging device category, while BoosterHealer ranks between second and fourth. In the cosmetics toner category, Zero Pore Pad holds the top spot.
Daol forecasted that APR’s Q4 sales will increase by 40% year-on-year to 212.9 billion KRW, with operating profit rising 13% to 39 billion KRW. Particularly, North American sales are expected to show a 100% year-on-year increase, reaching 59.8 billion KRW.
The firm concluded, "In the short term, expanding B2B retailer contracts in key markets and entering non-core markets will be effective. In the mid-to-long term, we expect APR to become a leading player in the anti-aging sector through the expansion of its medical device business."
Alphabiz Reporter Kim SangJin(letyou@alphabiz.co.kr)
